Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-(3-hydroxypropoxy)-1,25-dihydroxyvitamin D3
2. 2-(3-hydroxypropoxy)calcitriol
3. 20-epi-1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3
4. 20-epi-ed-71
5. 20-epi-eldecalcitol
6. Ed 71
7. Ed-71
1. Edirol
2. Ed-71
3. 104121-92-8
4. 2-(3-hydroxypropoxy)-1,25-dihydroxyvitamin D3
5. I2jp8ue90h
6. (1r,2r,3r,5z)-5-[(2e)-2-[(1r,3as,7ar)-1-[(2r)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-2-(3-hydroxypropoxy)-4-methylidenecyclohexane-1,3-diol
7. 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3
8. Ed 71
9. (5z,7e)-(1r,2r,3r)-2-(3-hydroxypropoxy)-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol
10. 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)cholecalciferol
11. (1r,2r,3r,5z,7e,14beta,17alpha)-2-(3-hydroxypropoxy)-9,10-secocholesta-5,7,10-triene-1,3,25-triol
12. 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3 / 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)cholecalciferol
13. Eldecalcitol [inn]
14. 2-(3-hydroxypropoxy)calcitriol
15. Eldecalcitol [inn:jan]
16. Unii-i2jp8ue90h
17. Hy-a0020
18. Edirol (tn)
19. Eldecalcitol (jan/inn)
20. Eldecalcitol [mi]
21. Eldecalcitol [jan]
22. Eldecalcitol [mart.]
23. Eldecalcitol [who-dd]
24. Gtpl2783
25. Schembl5457151
26. Chembl4297608
27. Chebi:73927
28. 2beta-(3-hydroxypropoxy)calcitriol
29. (1s,2s,3s,z)-5-((e)-2-((1r,7ar)-1-((r)-6-hydroxy-6-methylheptan-2-yl)-7a-methylhexahydro-1h-inden-4(2h)-ylidene)ethylidene)-2-(3-hydroxypropoxy)-4-methylenecyclohexane-1,3-diol; Eldecalcitol
30. Ex-a5554
31. Zinc3934328
32. Ct-081
33. Lmst03020477
34. Akos025312299
35. Cs-0363
36. Db05295
37. 9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol, 2-(3-hydroxypropoxy)-, (1alpha,2beta,3beta,5z,7e)-
38. Ac-26354
39. D07578
40. 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)-cholecalciferol
41. (1r,2r,3r,5z,7e)-2-(3-hydroxypropoxy)-9,10-secocholesta-5,7,10-triene-1,3,25-triol
42. (5z,7e)-2.beta.-(3-hydroxypropoxy)-9,10-secocholesta-5,7,10(19)-triene-1.alpha.,3.beta.,25-triol
43. Ed9
Molecular Weight | 490.7 g/mol |
---|---|
Molecular Formula | C30H50O5 |
XLogP3 | 4.3 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 10 |
Exact Mass | 490.36582469 g/mol |
Monoisotopic Mass | 490.36582469 g/mol |
Topological Polar Surface Area | 90.2 Ų |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Complexity | 784 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 7 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 2 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in osteoporosis.
Bone Density Conservation Agents
Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. (See all compounds classified as Bone Density Conservation Agents.)
Eldecalcitol [1a,25-DIHYDROXY-2-(3-hydroxypropoxy)vitamin D3] is an analog of 1a,25-dihydroxyvitamin D3 [1,25(OH)2D3], bearing a hydroxypropoxy residue at the 2b position. Eldecalcitol is also effective in increasing bone mass and was able to enhance bone strength in rodents. It binds to the vitamin D receptor (VDR) with less affinity but binds to vitamin D-binding protein with higher affinity than 1,25(OH)2D, showing a long half-life in plasma.
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?